• Cy3 TSA Fluorescence System Kit: Unveiling Quantitative Sign

  2026-05-20

  Explore how the Cy3 TSA Fluorescence System Kit empowers quantitative, high-sensitivity detection of biomolecules in immunohistochemistry and beyond. This article uniquely bridges molecular amplification principles with practical assay optimization, providing actionable insights for research excellence.

• p-Cresyl Sulfate Drives Valvular Calcification via Klotho/SI

  2026-05-19

  The reference study demonstrates that p-cresyl sulfate, a key uremic toxin, directly promotes calcification in aortic valvular interstitial cells by perturbing klotho and SIRT1 signaling pathways. These findings clarify how p-tolyl hydrogen sulfate exacerbates cardiovascular risk in chronic kidney disease, highlighting intervention points for future vascular complication studies.

• Ibrexafungerp (MK 3118): Mechanism, Efficacy, and Clinical L

  2026-05-19

  Ibrexafungerp is a novel oral triterpenoid antifungal targeting 1,3-β-D-glucan synthase, demonstrating potent activity against fluconazole- and echinocandin-resistant Candida species. Its unique mechanism and efficacy in acidic environments support its use in vulvovaginal and invasive candidiasis, as confirmed by multiple in vitro and in vivo studies.

• XAV939 Inhibition of Wnt/β-catenin Does Not Ameliorate UC In

  2026-05-18

  This study rigorously evaluated the effect of XAV939-mediated inhibition of the Wnt/β-catenin pathway and SOX9 on inflammation in a dextran sulfate sodium (DSS)-induced ulcerative colitis (UC) mouse model. Despite effectively suppressing Wnt/β-catenin signaling, XAV939 did not reduce intestinal inflammation, highlighting the complexity of UC pathogenesis and the need for refined mechanistic targeting.

• P2Y2 Receptor Activation Drives Microglial Aβ Clearance in A

  2026-05-18

  Kim et al. reveal that nucleotides released by amyloid β1–42-treated microglia activate P2Y2 receptors, boosting microglial migration and amyloid uptake—a process crucial for amyloid clearance in Alzheimer’s disease. This mechanistic insight positions P2Y2R as a potential therapeutic target and provides a foundation for experimental modulation of neuroimmune signaling.

• Dimethyloxalylglycine (DMOG): Technical Guidance for Hypoxia

  2026-05-17

  Dimethyloxalylglycine (DMOG) is a cell-permeable inhibitor of prolyl-4-hydroxylase domain enzymes, providing a controlled method to stabilize hypoxia-inducible factors in vitro and in vivo. It is recommended for research workflows focused on hypoxia signaling pathway modeling and inflammation studies, but is not suitable for diagnostic or clinical applications.

• Pseudo-UTP in mRNA Synthesis: Beyond Stability to Immune Eng

  2026-05-16

  Explore how pseudo-modified uridine triphosphate (Pseudo-UTP) advances mRNA synthesis with pseudouridine modification, not only enhancing RNA stability but also enabling precise immune modulation. This article delivers actionable protocol guidance and a unique analysis of UTR-based translational control, extending beyond prior reviews.

• Sunitinib: Multi-Targeted Receptor Tyrosine Kinase Inhibitor

  2026-05-15

  Sunitinib empowers cancer researchers to probe RTK-driven pathways, angiogenesis, and apoptosis with precision, especially in challenging models like ATRX-deficient gliomas and renal cell carcinoma. This guide demystifies advanced protocol enhancements, troubleshooting, and data-driven approaches for maximizing reproducibility and translational relevance.

• IL-21-Dependent Ly6C+Ly6G+CD4+ T Cells Enhance Antibacterial

  2026-05-15

  This study identifies a novel IL-21-dependent Ly6C+Ly6G+CD4+ T cell subset in the lungs that boosts macrophage-mediated antibacterial defense during Actinobacillus pleuropneumoniae infection in mice. By integrating high-dimensional mass cytometry and functional assays, the authors reveal how IL-21 signaling orchestrates immune cell differentiation and function, suggesting new therapeutic targets for bacterial pneumonia.

• Caspofungin: Applied Workflows for Antifungal Research Excel

  2026-05-14

  Caspofungin is a benchmark lipopeptide antifungal drug enabling researchers to dissect Candida cell wall biosynthesis and overcome azole resistance. This guide translates recent breakthroughs and experimental best practices into actionable protocols and troubleshooting strategies for high-reproducibility antifungal assays.

• HIV-1 Infection Sensitizes Brain Pericytes to Glutamate-Indu

  2026-05-14

  This study demonstrates that HIV-1 infection and latency compromise DNA damage response pathways in brain vascular pericytes, making them more susceptible to glutamate and inflammatory cytokine-induced injury. These findings reveal a potential mechanism for blood-brain barrier disruption in HIV-associated neurocognitive disorders and provide a framework for future DNA repair research in neuroinflammation.

• Lanabecestat (AZD3293): BACE1 Inhibition in Alzheimer's Rese

  2026-05-13

  Lanabecestat (AZD3293) is a potent, orally active BACE1 inhibitor designed for Alzheimer's disease research. It reduces amyloid-beta production without impairing synaptic function when used at moderate doses. This article details its mechanism, evidence base, and workflow integration for rigorous scientific applications.

• CUDC-907: Technical Guidance for Dual PI3K and HDAC Inhibiti

  2026-05-13

  CUDC-907 offers a potent approach for researchers needing simultaneous inhibition of PI3K/AKT and histone deacetylase pathways in cancer cell models. It is intended for controlled in vitro research only and should not be used in diagnostic or clinical workflows.

• Apicidin: A Histone Deacetylase Inhibitor for Precision Cell

  2026-05-12

  Apicidin, a potent histone deacetylase inhibitor, offers unique selectivity for HDAC3 and HDAC6, enabling targeted epigenetic modulation in both cancer and reproductive models. This article provides actionable workflows and troubleshooting strategies to maximize reproducibility and interpretability when deploying Apicidin as a cancer cell growth inhibitor or anti-angiogenesis compound.

• Cyclophilin A’s Essential Role in Cyclosporine-Mediated Immu

  2026-05-12

  The reference study demonstrates that cyclophilin A deficiency confers resistance to cyclosporine-induced immunosuppression in mice, establishing cyclophilin A as the critical intracellular mediator of cyclosporine’s effects. These findings refine our mechanistic understanding of immunosuppressive drug action and provide a foundation for more targeted approaches in transplantation immunology research.

16450 records 1/1097 page Next 12345 下5页 Last page